<DOC>
	<DOCNO>NCT02926352</DOCNO>
	<brief_summary>There two specific aim study . Aim 1 test whether low-level laser therapy ( LLLT ) enhance efficacy fear extinction training modification pathological fear . Aim 2 investigate efficacy low-level laser therapy ( LLLT ) stand-alone intervention anxiety/phobias .</brief_summary>
	<brief_title>Effects Low-Level Laser Stimulation With Without Fear Extinction Training</brief_title>
	<detailed_description>Preliminary research non-human animal suggest LLLT ( i.e. , ultra low dos transcranial infrared light ) enhance retention fear extinction learn regulate neuronal metabolic activity apply ventromedial prefrontal cortex ( vmPFC ) . Furthermore , evidence previous uncontrolled trial human suggest LLLT ( outside context extinction training ) lead significant decrease symptom depression anxiety apply right left dorsolateral prefrontal cortex ( dlPFC ) . The first aim study test whether LLLT boost fear reduction extinction training human . A second aim study investigate efficacy LLLT stand-alone anxiolytic intervention randomize controlled trial . Individuals age 18-65 elevated fear one four domain ( e.g. , fear enclose space , fear contamination , fear public speaking , anxiety sensitivity ) randomly assign one four treatment arm ( 1 ) Extinction Training LLLT , ( 2 ) Extinction Training Sham LLLT , ( 3 ) LLLT alone , ( 4 ) Sham LLLT alone . To determine eligibility , participant undergo online prescreen face-to-face screening assessment . Participants qualify study complete baseline ( pre-treatment ) assessment , follow immediately treatment procedure post-treatment assessment . Participants return lab average 14 day treatment complete follow-up assessment . Participants complete two behavioral approach test ( treatment context generalization context ) baseline , post-treatment , follow-up , battery self-report questionnaire baseline follow-up .</detailed_description>
	<mesh_term>Phobic Disorders</mesh_term>
	<criteria>1 . Ages 1865 2 . Behavioral Approach Test ( BAT ) peak fear rating equal great 50/100 BATs ( i.e. , treatment generalization context ) . 1 . High risk suicide determine clinical assessment , occur participant indicates currently experience suicidal ideation depression module Mini International Neuropsychiatric Inventory , item 9 Beck Depression Inventory . 2 . Psychotropic medication take within past 4 week . 3 . Currently Receiving treatment fear domain question . 4 . Presence medical condition ( i.e. , pregnancy , seizure disorder , respiratory disorder , cardiovascular disease ) would contraindicate participation one treatment assessment activity determine Medical History Questionnaire . 5 . Active neurological condition ( epilepsy stroke ) determine Medical History Questionnaire .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>LLLT</keyword>
	<keyword>LLLS</keyword>
	<keyword>Low-Level Laser Stimulation</keyword>
	<keyword>Low-Level Laser Therapy</keyword>
	<keyword>Low-Level Light Therapy</keyword>
	<keyword>Transcranial infrared light stimulation</keyword>
	<keyword>Near-infrared light</keyword>
	<keyword>Photobiomodulation</keyword>
	<keyword>Fear Extinction</keyword>
	<keyword>Exposure Therapy</keyword>
	<keyword>Claustrophobia</keyword>
	<keyword>Fear enclose space</keyword>
	<keyword>Fear contamination</keyword>
	<keyword>Fear public speaking</keyword>
	<keyword>Anxiety sensitivity</keyword>
	<keyword>Cytochrome oxidase</keyword>
	<keyword>Memory consolidation</keyword>
	<keyword>Cognitive enhancer</keyword>
</DOC>